An observational study in Premature Infants, Pierre Robin Sequence and Feeding Disorder, sponsored by Hospices Civils de Lyon. Completed at 1 site in France. Open to participants aged Up to 29 Weeks. Per ClinicalTrials.gov, last updated 2026-05-22.
Sponsored by Hospices Civils de Lyon · Observational
The NUTROBIN study aims to analyze sucking in two populations of vulnerable children who require intensive and prolonged care, and whose treatment has an impact on the subsequent development of oral function. This development has a significant impact on the overall psychomotor development.
Justification for the NUTROBIN study:
This study will help to better define the sucking profile of infants with Pierre Robin sequence in order to determine the actions to be taken to support oral function in these infants from the first weeks of life and limit the neurodevelopmental consequences and the impact on the quality of life of the infant and their family caused by oral function disorders.
The public interest of the study lies in the fact that it will clarify the specificities of the sucking and swallowing profile of infants with Pierre Robin sequence, enable families to be better informed about these children's oral disorders, and thus offer targeted, personalized multidisciplinary care (paediatrician, speech therapist, dietitian).
Patients included in the NUTRIO or DYSROBIN studies with succiometry measurements.
Exclusion Criteria:
Children with Pierre Robin syndrome included in the DYSROBIN study who underwent succiometry as part of the study.
Other: Succiometry
Extremely pemature infants included in the NUTRIO study who underwent succiometry as part of the study.
Other: Succiometry
Comparison of data measured by succiometry between children with Pierre Robin syndrome (DYSROBIN; closed) and very premature infants (NUTRIO; ongoing).
Number of suction and crushing peaks
The primary endpoint is the number of suction and crushing peaks
Time frame: between 33 and 36 weeks postconceptional age
This study is completed, as verified in May 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Hospices Civils de Lyon